Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Full Text
See detailRenforcer la formation en sciences humaines en réduisant l’histoire-géo : cherchez l’erreur!
Jadoulle, Jean-Louis ULg

E-print/Working paper (2012)

Cette "carte blanche" fait suite à la décision de la Ministre de l'Enseignement obligatoire, Marie-Dominique Simonet, de réviser les grilles - horaires de l'enseignement qualifiant. Elle reprend la teneur ... [more ▼]

Cette "carte blanche" fait suite à la décision de la Ministre de l'Enseignement obligatoire, Marie-Dominique Simonet, de réviser les grilles - horaires de l'enseignement qualifiant. Elle reprend la teneur d'une lettre qui lui a été adressée et qui a été co-signée par plus de 140 enseignants, formateurs d'enseignants et membres de la société civile. [less ▲]

Detailed reference viewed: 24 (2 ULg)
See detailRenier de Huy
George, Philippe ULg

in Dictionnaire d’Histoire de l’art du Moyen Age occidental (2009)

Detailed reference viewed: 7 (0 ULg)
Full Text
See detailRenier de Huy : auteur véritable des fonds baptismaux de Saint-Barthélemy de Liège et le prétendu Lambert Patras
Kurth, Godefroid ULg

in Bulletins de l'Académie Royale des Sciences, des Lettres et des Beaux-Arts de Belgique (1903), 8

Detailed reference viewed: 41 (0 ULg)
Full Text
Peer Reviewed
See detailRenin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials.
Scheen, André ULg

in Diabètes & Métabolism (2004), 30(6), 487-96

Most individuals with arterial hypertension or congestive heart failure are insulin-resistant and at a higher risk of developing type 2 diabetes (T2DM). The inhibition of the renin-angiotensin system (RAS ... [more ▼]

Most individuals with arterial hypertension or congestive heart failure are insulin-resistant and at a higher risk of developing type 2 diabetes (T2DM). The inhibition of the renin-angiotensin system (RAS), using an angiotensin converting enzyme inhibitor (ACEI) or a selective angiotensin receptor AT1 blocker (ARB), may exert favourable metabolic effects capable of preventing T2DM in high risk individuals. We performed a meta-analysis of randomised clinical trials (RCTs) assessing the effects of RAS inhibition on the incidence of new cases of T2DM in patients with arterial hypertension or congestive heart failure. Ten RCTs with cardiovascular prognosis as primary endpoints analysed the incidence of T2DM as secondary endpoints or as post-hoc analysis after a mean follow-up of 1 to 6 years: five with an ACEI and five with an ARB, compared with a placebo (n=4) or a reference drug (beta-blocker or diuretic: n=5; amlodipine: n=2). Eight RCTs concerned hypertensive patients: STOP Hypertension-2 (lisinopril or enalapril vs beta-blocker or diuretic), CAPPP (captopril vs thiazide or beta-blocker), HOPE (ramipril vs placebo), ALLHAT (lisinopril vs chlorthalidone and lisinopril vs amlodipine), LIFE (losartan vs atenolol), SCOPE (candesartan vs placebo), ALPINE (candesartan vs placebo) and VALUE (valsartan vs amlodipine). Two RCTs concerned patients with congestive heart failure: SOLVD (enalapril vs placebo) and CHARM-overall programme (candesartan vs placebo). Overall, 2 675 new cases of T2DM (7.40%) were observed in the group of 36 167 patients receiving a treatment with ACEI or ARA as compared with 3 842 events (9.63%) in the group of 39 902 control patients. A mean weighed relative risk reduction of new T2DM of 22% (95% CI: 18, 26; p<0.00001) was observed after RAS inhibition. The beneficial effect was similar with ACEIs and with ARBs as well as in patients with hypertension and in those with heart failure, and was also present whatever the comparator (placebo or beta-blockers/diuretics or amlodipine). The number needed-to-treat to avoid one new case of T2DM averaged 45 patients over 4-5 years. In conclusion, RAS inhibition consistently and significantly reduces the incidence of T2DM in individuals with arterial hypertension or with congestive heart failure. Considering the pandemic of T2DM, such pharmacological approach deserves further attention among the strategies aiming at preventing T2DM. [less ▲]

Detailed reference viewed: 26 (2 ULg)
Full Text
Peer Reviewed
See detailRenin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms.
Scheen, André ULg

in Diabètes & Métabolism (2004), 30(6), 498-505

The inhibition of the renin-angiotensin system (RAS) with either angiotensin converting enzyme inhibitors (ACEIs) or AT1 angiotensin receptor blockers (ARBs) consistently and significantly reduces the ... [more ▼]

The inhibition of the renin-angiotensin system (RAS) with either angiotensin converting enzyme inhibitors (ACEIs) or AT1 angiotensin receptor blockers (ARBs) consistently and significantly reduces the incidence of type 2 diabetes in patients with hypertension or congestive heart failure. The mechanisms underlying this protective effect appear to be complex and may involve an improvement of both insulin sensitivity and insulin secretion. These two effects may result, at least in part, from the well known effects of these pharmacological agents on the vascular system on the one hand, on the ionic balance on the other hand. Indeed, the vasodilation induced by ACEIs or ARBs could improve the blood circulation in skeletal muscles, thus favouring peripheral insulin action, but also in the pancreas, thus promoting insulin secretion. Preserving cellular potassium and magnesium pools by blocking the aldosterone effects could also improve both cellular insulin action and insulin secretion. However, besides these classical effects, new mechanisms have been recently suggested. A direct effect of the inhibition of angiotensin and/or of the enhancement of bradykinin on various steps of the insulin cascade signalling has been described as well an increase in GLUT4 glucose transporters after RAS inhibition. Furthermore, it has been demonstrated that angiotensin II inhibits adipogenic differentiation of human adipocytes via A1 receptors and, therefore, it has been hypothesised that RAS blockade may prevent diabetes by promoting the recruitment and differentiation of adipocytes. Finally, some lipophilic ARBs appear to induce PPAR-gamma activity in the adipose tissue. Hence, the protection against type 2 diabetes observed after RAS inhibition may be partially linked to a thiazolidinedione-like effect. In conclusion, numerous physiological and biochemical mechanisms could explain the protective effect of RAS inhibition against the development of type 2 diabetes in individuals with arterial hypertension or congestive heart failure. What might be the main mechanism in the overall protection effect of ACEIs or ARBs remains an open question. [less ▲]

Detailed reference viewed: 28 (3 ULg)
Full Text
Peer Reviewed
See detailRENO, a European Postmarket Surveillance Registry, confirms effectiveness of coronary brachytheraypy in routine clinical practice.
Coen, V; Serruys, P; Sauerwein, W et al

in International Journal of Radiation, Oncology, Biology, Physics (2003), 55(4), 1019-1026

Purpose: To assess, by a European registry trial, the clinical event rate in patients with discrete stenotic lesions of coronary arteries (de novo or restenotic) in single or multiple vessels (native or ... [more ▼]

Purpose: To assess, by a European registry trial, the clinical event rate in patients with discrete stenotic lesions of coronary arteries (de novo or restenotic) in single or multiple vessels (native or bypass grafts) treated with -radiation. Methods and Materials: Between April 1999 and September 2000, 1098 consecutive patients treated in 46 centers in Europe and the Middle East with the Novoste Beta-Cath System were included in Registry Novoste (RENO). Results: Six-month follow-up data were obtained for 1085 patients. Of 1174 target lesions, 94.1% were located in native vessels and 5.9% in a bypass graft; 17.7% were de novo lesions, 4.1% were restenotic, and 77.7% were in-stent restenotic lesions. Intravascular brachytherapy was technically successful in 95.9% of lesions. Multisegmental irradiation, using a manual pullback stepping maneuver to treat longer lesions, was used in 16.3% of the procedures. The in-hospital rate of major adverse cardiac events was 1.8%. At 6 months, the rate was 18.7%. Angiographic follow-up was available for 70.4% of the patients. Nonocclusive restenosis was seen in 18.8% and total occlusion in 5.7% of patients. A combined end point for late (30–180 days) definitive or suspected target vessel closure was reached in 5.4%, but with only 2% of clinical events. Multivariate analysis was performed for major adverse cardiac events and late thrombosis. Conclusion: Data obtained from the multicenter RENO registry study, derived from a large cohort of unselected consecutive patients, suggest that the good results of recent randomized controlled clinical trials can be replicated in routine clinical practice. © 2003 Elsevier Science Inc. [less ▲]

Detailed reference viewed: 30 (0 ULg)
See detail"Renonciation à succession" (commentaire de l'article 1185 du Code judiciaire)
Moreau, Pierre ULg

in Les procédures particulières et le droit judiciaire familial, P. Moreau (coord.), in La jurisprudence du Code judiciaire commentée, vol. III, G. de Leval (dir.) (2010)

Detailed reference viewed: 103 (5 ULg)
See detailLa renonciation
Moreau, Pierre ULg

in Moreau, Pierre (Ed.) Libéralités et successions (2012)

Detailed reference viewed: 20 (6 ULg)
Full Text
See detailRenormalization in effective theories: Prescriptions for kaon-nucleon resonance parameters
Semenov-Tyan-Shanskiy, Kirill ULg

in Lipatov, L.; Kim, V. (Eds.) Proceedings of First International Workshop, Hadron Structure and QCD, from low to high energies, Repino, St. Petersburg, Russia, 18-22 May 2004 (2004)

Detailed reference viewed: 15 (0 ULg)
Full Text
See detailRenormalization prescriptions and bootstrap in effective theories
Vereshagin, Vladimir; Semenov-Tyan-Shanskiy, Kirill ULg; Vereshagin, Alexander

in High energy physics and quantum field theory. Proceedings, 18th International Workshop, QFTHEP 2004, St. Petersburg, Russia, June 17-23, 2004 (2004)

Detailed reference viewed: 8 (0 ULg)
Full Text
See detailRenormalization programme for effective theories
Vereshagin, Vladimir; Semenov-Tyan-Shanskiy, Kirill ULg; Vereshagin, Alexander

in Lipatov, L.; Kim, V. (Eds.) Proceedings of First International Workshop, Hadron Structure and QCD, from low to high energies, Repino, St. Petersburg, Russia, 18-22 May 2004 (2004)

Detailed reference viewed: 13 (0 ULg)
Full Text
See detailRenouées asiatiques: Fiche synthétique de gestion
Delbart, Emmanuel ULg; Mahy, Grégory ULg

Learning material (2010)

Detailed reference viewed: 1007 (55 ULg)
Peer Reviewed
See detailLe renouveau cosaque
Bachkatov, Nina ULg; Wilson, Andrew

in Transitions : Ex-Revue des Pays de L'est (1994), 35-1

Detailed reference viewed: 16 (0 ULg)
Full Text
See detailLe renouveau de colza d'hiver en Belgique.
Cartrysse, C.; Cors, F.; Wathelet, Jean-Paul ULg

in GCIRC Bulletin (1989)

Detailed reference viewed: 17 (1 ULg)
Full Text
Peer Reviewed
See detailRenouveler la gestion du risque par l’ouverture à un système de vigilance ? Le cas de la fièvre catarrhale ovine
Fallon, Catherine ULg; Piet, Grégory ULg; Thiry, Etienne ULg et al

in VertigO : la Revue Electronique en Sciences de l'Environnement (2012), 12(3),

This contribution proposed by a multidisciplinary group of veterinary and political scientists gives an analysis of the transformations of an epidemiosurveillance system dedicated to animal diseases, when ... [more ▼]

This contribution proposed by a multidisciplinary group of veterinary and political scientists gives an analysis of the transformations of an epidemiosurveillance system dedicated to animal diseases, when confronted to new emerging threats in the wake of global changes, within the frame of risk management. The research field refers to the emergence of bluetongue virus serotype 8 in 2006 in Belgium. This research is complemented with the results of a recent survey based on Delphi method involving relevant public servants and scientists, which showed that most of the means proposed by the authorities are based on the logic of known risk management. However we can identify attempts for renewal and organisational learning, especially with the proposal of a new vigilance system. This system develops two dimensions (prevention and anticipation of the catastrophe) and tries to accommodate the surveillance system reactivity against uncertain events. Finally the article draws two drivers for change, by admitting the persistence of unavoidable uncertainty and by recognising the importance for opening up expert knowledge. [less ▲]

Detailed reference viewed: 31 (10 ULg)
Full Text
See detailRenouveler la rapport du travail à la nature
Mormont, Marc ULg

in Revue Nouvelle (2007), (1-2), 46-49

Depuis un siècle et demi, la modernisation du monde rural, marquée par une rationalisation croissante, s’est faite au détriment de la gestion en commun. La bureaucratisation du vivant transforme les ... [more ▼]

Depuis un siècle et demi, la modernisation du monde rural, marquée par une rationalisation croissante, s’est faite au détriment de la gestion en commun. La bureaucratisation du vivant transforme les agriculteurs d’artisans en techniciens. À condition de mener une réflexion sur le travail et la nature, l’économie sociale peut apporter un projet à un monde rural qui associerait marché, consommation et action publique [less ▲]

Detailed reference viewed: 20 (4 ULg)
Full Text
See detailRenouvellement de la couche cornée
Pierard, Gérald ULg; Nikkels, Arjen ULg; Pierard-Franchimont, Claudine ULg

in Desquamation Adhesion (1995)

Detailed reference viewed: 5 (0 ULg)